Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2015.07.641
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2015
Authors
Publisher
Elsevier BV